To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Maze Therapeutics on Tuesday filed plans for an initial public offering that could become the ...
A Quick Take On Maze Therapeutics, Inc. Maze Therapeutics, Inc. (MAZE) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The company is ...